These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 12473575)
1. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer. Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592 [TBL] [Abstract][Full Text] [Related]
3. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699 [TBL] [Abstract][Full Text] [Related]
4. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704 [TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310 [TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer. Hsu HS; Wen CK; Tang YA; Lin RK; Li WY; Hsu WH; Wang YC Clin Cancer Res; 2005 Aug; 11(15):5410-6. PubMed ID: 16061855 [TBL] [Abstract][Full Text] [Related]
7. Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer. Wang J; Lee JJ; Wang L; Liu DD; Lu C; Fan YH; Hong WK; Mao L Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6119-25. PubMed ID: 15447998 [TBL] [Abstract][Full Text] [Related]
8. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection? Kim YT; Lee SH; Sung SW; Kim JH Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047 [TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma. Maruyama R; Sugio K; Yoshino I; Maehara Y; Gazdar AF Cancer; 2004 Apr; 100(7):1472-7. PubMed ID: 15042681 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer. Han JY; Choi BG; Choi JY; Lee SY; Ju SY Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer]. Yu ZH; Wang YC; Chen LB; Song Y; Liu C; Xia XY; Lin Q; Ma CY Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):284-7. PubMed ID: 18788633 [TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma. Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787 [TBL] [Abstract][Full Text] [Related]
13. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Kim DH; Kim JS; Ji YI; Shim YM; Kim H; Han J; Park J Cancer Res; 2003 Jul; 63(13):3743-6. PubMed ID: 12839968 [TBL] [Abstract][Full Text] [Related]
15. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590 [TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747 [TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Kim DH; Nelson HH; Wiencke JK; Christiani DC; Wain JC; Mark EJ; Kelsey KT Oncogene; 2001 Mar; 20(14):1765-70. PubMed ID: 11313923 [TBL] [Abstract][Full Text] [Related]
18. Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Buttitta F; Martella C; Barassi F; Felicioni L; Salvatore S; Rosini S; D'Antuono T; Chella A; Mucilli F; Sacco R; Mezzetti A; Cuccurullo F; Callahan R; Marchetti A Clin Cancer Res; 2005 May; 11(9):3198-204. PubMed ID: 15867213 [TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features. Kim DS; Kim MJ; Lee JY; Lee SM; Choi JY; Yoon GS; Na YK; Hong HS; Kim SG; Choi JE; Lee SY; Park JY Mol Carcinog; 2009 Dec; 48(12):1109-15. PubMed ID: 19554572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]